Avior Wealth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-622
| Closed | -$204K | – | 2353 |
|
|
2024
Q4 | $204K | Sell |
622
-85
| -12% | -$27.8K | 0.01% | 695 |
|
|
2024
Q3 | $212K | Hold |
707
| – | – | 0.01% | 678 |
|
|
2024
Q2 | $233K | Sell |
707
-242
| -26% | -$79.7K | 0.01% | 637 |
|
|
2024
Q1 | $376K | Buy |
949
+851
| +868% | +$337K | 0.02% | 523 |
|
|
2023
Q4 | $34.5K | Sell |
98
-1,844
| -95% | -$649K | ﹤0.01% | 797 |
|
|
2023
Q3 | $729K | Buy |
1,942
+1,780
| +1,099% | +$668K | 0.05% | 249 |
|
|
2023
Q2 | $62K | Buy |
162
+14
| +9% | +$5.36K | ﹤0.01% | 718 |
|
|
2023
Q1 | $51.3K | Buy |
+148
| New | +$51.3K | ﹤0.01% | 762 |
|
|
2022
Q1 | – | Sell |
-13
| Closed | -$6K | – | 1266 |
|
|
2021
Q4 | $6K | Buy |
13
+10
| +333% | +$4.62K | ﹤0.01% | 872 |
|
|
2021
Q3 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 1036 |
|